At the end of January, the MED issued Industry Bulletin 17-01 regarding a change to total yeast and mold testing methodologies.  The Colorado Department of Public Health and Environment increased the required incubation time for these types of tests in order to ensure accuracy.  While this will certainly have an impact on test turnaround times, this also impacts licensees that are process validated.

Specifically, “…the MED is requiring all Retail Marijuana Cultivation Licenses (RMC) and Retail Marijuana Products Manufacturing Facility Licenses (RMPMF) that have obtained process validation according to MED Rule R 1501 (B) to submit a single Test Batch from a Harvest Batch or Production Batch so that it can be tested for total yeast and mold.”  The bulletin goes on to explain that this test was required to be performed in February (if there was a harvest or production batch in February).  A passing test is required to maintain the validation.

As we’ve written about before, because of the frequency of bulletins, position statements, and rulemaking, it can be extremely difficult to stay on top of everything.  That’s where Complia comes in!

When this bulletin went out, our team of dedicated compliance analysts worked closely with our clients that were process validated to ensure appropriate measures were taken to comply with this bulletin.  As a reminder, Complia is the only software on the market today that helps businesses determine their level of compliance with testing regulations including process validation.

We’re already starting to hear rumors about further changes to testing requirements.  We expect things to continue to evolve over the coming years.  For this reason, it’s important to think about leveraging tools and services that help keep your business on track!
If you’re interested in seeing Complia in action, drop us a line at to schedule a demo.

Yours in Compliance,
Team Complia